Synapse - Works

Results (2639)

A phase 2 study of idelalisib monotherapy in previously untreated patients ≥ 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)

Meeting Abstract

Zelenetz, A.; Lamanna, N.; Kipps, T.; Coutre, S.; O'Brien, S.; Graves, J.; Ye, W.; Dubowy, R.; Flinn, I.
British Journal of Haematology (2016)

Fulltext@MSK | Save

Safety of idelalisib in B-cell malignancies: Integrated analysis of eight clinical trials

Meeting Abstract

Coutre, S.; Barrientos, J.; Brown, J.; De Vos, S.; Furman, R.; Keating, M.; O'Brien, S.; Pagel, J.; Sharman, J.; Zelenetz, A.; more...
British Journal of Haematology (2016)

Fulltext@MSK | Save

Idelalisib plus bendamustine and rituximab (BR) is superior to BR alone in patients with relapsed/refractory chronic lymphocytic leukemia: Results of a phase 3 randomized double-blind placebo-controlled study

Meeting Abstract

Zelenetz, A.; Robak, T.; Coiffier, B.; Delgado, J.; Marlton, P.; Adewoye, A.; Kim, Y.; Dreiling, L.; Hillmen, P.
British Journal of Haematology (2016)

Fulltext@MSK | Save

Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium

Journal Article

Noy, A.; Lensing, S. Y.; Moore, P. C.; Gupta, N.; Aboulafia, D.; Ambinder, R.; Baiocchi, R.; Dezube, B. J.; Henry, D.; Kaplan, L.; more...
Leukemia and Lymphoma (2016)

Fulltext@MSK | Save

Clonal B cells in Waldenstrom's macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling

Journal Article

Argyropoulos, K. V.; Vogel, R.; Ziegler, C.; Altan-Bonnet, G.; Velardi, E.; Calafiore, M.; Dogan, A.; Arcila, M.; Patel, M.; Knapp, K.; more...
Leukemia (2016)

Fulltext@MSK | Save

Managing patients with cutaneous B-cell and T-cell lymphomas other than mycosis fungoides

Journal Article

Kheterpal, M.; Mehta-Shah, N.; Virmani, P.; Myskowski, P. L.; Moskowitz, A.; Horwitz, S. M.
Current Hematologic Malignancy Reports (2016)

Fulltext@MSK | Save

The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of <= 12 months

Journal Article

Lunning, M. A.; Migliacci, J. C.; Hilden, P.; Devlin, S. M.; Castro-Malaspina, H.; Giralt, S.; Perales, M. A.; Zelenetz, A. D.; Moskowitz, C. H.; Sauter, C. S.
British Journal of Haematology (2016)

Fulltext@MSK | Save

Central nervous system involvement in T-cell lymphoma: A single center experience

Journal Article

Gurion, R.; Mehta, N.; Migliacci, J. C.; Zelenetz, A.; Moskowitz, A.; Lunning, M.; Moskowitz, C.; Hamlin, P.; Horwitz, S.
Acta Oncologica (2016)

Fulltext@MSK | Save

US intergroup trial of response-adapted therapy for stage III to IV Hodgkin lymphoma using early interim fluorodeoxyglucose-positron emission tomography imaging: Southwest Oncology Group S0816

Journal Article

Press, O. W.; Li, H.; Schöder, H.; Straus, D. J.; Moskowitz, C. H.; LeBlanc, M.; Rimsza, L. M.; Bartlett, N. L.; Evens, A. M.; Mittra, E. S.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Tumor lysis syndrome

Journal Article

Chung, H. H.; Tsyvkin, E.
Hospital Medicine Clinics (2016)

Fulltext@MSK | Save